{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-000948","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2025-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.232432+00:00","generated_at":"2026-05-18T08:52:24.555704+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Renovaro exchanges $9.7M secured debt for $16.1M convertible notes, converted to 53.6M shares","bullets":["Exchanged $9.7M in secured promissory notes for $16.1M in convertible notes (65% premium).","Convertible notes immediately converted into 53.6M shares at $0.30/share (premium to market).","Transaction eliminated $9.7M secured debt; no cash proceeds received by the company.","Conversion price exceeded July 7 closing price, so no Nasdaq stockholder approval needed.","Issuance to accredited existing shareholders exempt from registration under Section 4(a)(2)/Reg D."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-000948","json":"https://secwatch.observer/filing/0001731122-25-000948.json","markdown":"https://secwatch.observer/filing/0001731122-25-000948.md","text":"https://secwatch.observer/filing/0001731122-25-000948.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000948/0001731122-25-000948-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000948/e6687_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T08:52:24.555704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}